US 11,746,337 B2
Purification of polymerase complexes
Helen Franklin, San Jose, CA (US); Cynthia Cech, Pleasanton, CA (US); Timothy Kellogg Craig, Campbell, CA (US); Aruna Ayer, Santa Clara, CA (US); Kirti Dhiman, Mountain View, CA (US); Natalie B. Chechelski Johnston, Redwood City, CA (US); Joshua N. Mabry, Woodside, CA (US); Arkadiusz Bibillo, Cupertino, CA (US); Peter Crisalli, Mountain View, CA (US); and Randall W. Davis, Santa Clara, CA (US)
Assigned to Roche Sequencing Solutions, Inc., Pleasanton, CA (US)
Filed by ROCHE SEQUENCING SOLUTIONS, INC., Pleasanton, CA (US)
Filed on May 11, 2020, as Appl. No. 16/871,973.
Application 16/871,973 is a division of application No. 15/989,109, filed on May 24, 2018.
Application 15/989,109 is a continuation of application No. PCT/EP2016/078781, filed on Nov. 25, 2016.
Claims priority of provisional application 62/373,973, filed on Aug. 11, 2016.
Claims priority of provisional application 62/295,010, filed on Feb. 13, 2016.
Claims priority of provisional application 62/260,194, filed on Nov. 25, 2015.
Prior Publication US 2020/0270589 A1, Aug. 27, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 9/12 (2006.01); C12Q 1/6869 (2018.01); B01L 9/00 (2006.01); C12N 9/96 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6874 (2018.01)
CPC C12N 9/1252 (2013.01) [C12Q 1/6869 (2013.01); B01L 9/527 (2013.01); C12N 9/96 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6874 (2013.01); C12Q 2525/301 (2013.01); C12Q 2565/50 (2013.01); C12Q 2565/631 (2013.01); C12Y 207/07007 (2013.01)] 8 Claims
 
1. A method for isolating a polymerase complex comprising
(a4) isolating active polymerase complexes by a method comprising:
(a4a) providing a reaction mixture comprising:
(i) a polymerase complex comprising:
(1) a nucleic acid adaptor for isolating active polymerase complexes, said adaptor having a single-stranded region comprising a primer recognition sequence, a runway sequence located 5′ to the primer recognition sequence, and a polymerase termination sequence located 5′ to the runway sequence, wherein said runway sequence comprises a nucleotide sequence having between 2 and 50 contiguous nucleotide bases selected from no more than three of the four nucleotide bases of adenine, cytosine, guanine, and thymine, the nucleotide base that is not contained in the runway sequence is designated as a stop base, said runway sequence functions as a template for polymerase-driven primer extension, and said polymerase termination sequence comprises at least one stop base that is effective to terminate any such polymerase-driven primer extension;
(2) a primer specific to the primer recognition sequence of the adaptor; and
(3) a polymerase enzyme; and
(ii) a nucleic acid sample, wherein the adaptor of the polymerase complex is ligated to said nucleic acid sample;
(a4b) providing a deoxynucleotide triphosphate (dNTP) mixture comprising only those dNTPs that are complementary to the nucleotide bases contained in the runway sequence of the adaptor, wherein one or more of the dNTPs is modified to include a capture moiety having affinity to a binding partner;
(a4c) combining the reaction mixture and the dNTP mixture to enable synthesis of a polynucleotide sequence complementary to the runway sequence by the activity of the polymerase to obtain a plurality of active polymerase complexes comprising extended runway complementary sequences having modified dNTPs incorporated therein;
(a4d) binding said active polymerase complexes to a solid phase support, wherein the capture moieties of the modified dNTPs are bound to binding partners on the solid phase support; and
(a4e) isolating said active polymerase complexes having extended runway complementary sequences from inactive polymerase complexes comprising unextended runway complementary sequences;
wherein said polymerase complex isolated according to (a4) optionally further comprises a nanopore to provide a nanopore-polymerase complex; and
(b) preparing a biochip by a method comprising either:
(b1) attaching said polymerase complex to a nanopore pre-formed in the membrane of said biochip to provide a nanopore-polymerase complex; or
(b2) inserting said nanopore-polymerase complexes obtained from (a) into the membrane of said biochip;
(c) optionally, sequencing a polynucleotide template by a method comprising:
(c1) providing tagged nucleotides or nucleotide analogs to said nanopore sequencing complex, wherein the tag of said tagged nucleotide is detectable with the aid of said nanopore;
(c2) carrying out a polymerization reaction with the aid of said polymerase coupled to said nanopore in said nanopore-sequencing complex, thereby incorporating an individual tagged nucleotide of said tagged nucleotides into a growing strand complementary to a sample polynucleotide template; and
(c3) detecting, with the aid of said nanopore, a tag associated with said individual tagged nucleotide during incorporation of said individual tagged nucleotide, wherein said tag is detected with the aid of said nanopore while said nucleotide is associated with said polymerase, thereby providing a sequence of said nucleic acid sample.